WOOJUNG BIO, Inc. (KOSDAQ: 215380)

Market Cap	39.54B
Revenue (ttm)	44.75B
Net Income (ttm)	1.18B
Shares Out	15.88M
EPS (ttm)	-53.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	313,288
Open	2,010.00
Previous Close	2,010.00
Day's Range	1,903.00 - 2,065.00
52-Week Range	1,100.00 - 4,300.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About WOOJUNG BIO

WOOJUNG BIO, Inc. provides research and laboratory services in Korea. The company offers environmental infection control. It also provides construction solutions, such as preventing clean and infected; hospital negative pressure isolation ward; pharmaceutical company's aseptic production rooms; general and animal laboratory; high-risk pathogen research facility; and HEPA box air conditioning systems. In addition, the company offers tab verification; equipment systems; space sterilizers, including HPV and plasmair; sterilizers other than autocla...

• Industry: Commercial Physical and Biological Research
• Founded: 1989
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 215380

Financial Performance

In 2023, WOOJUNG BIO's revenue was 38.62 billion, a decrease of -17.70% compared to the previous year's 46.92 billion. Losses were -5.05 billion, 168.8% more than in 2022.